Free, private, no obligation
Hurt by a medication, device, or exposure? Start with clear answers.
Plain-language answers on active legal claims, with official sources, and a free, private way to ask a participating law firm.
Free to requestA review request costs nothing and you can stop at any step.
You choose what to shareConsent is never pre-checked, and we explain who may contact you.
Sources on every pageCourt, FDA, and agency records, linked, dated, and checked daily.
No promised outcomesA review is not a case, and we never quote settlement amounts.
Campaigns people are reviewing now
Four steps. You decide at every one.
Submitting a request does not create an attorney-client relationship and does not pause any legal deadline.
- Find what happened to youBrowse by situation or search a product. Each page lists the criteria participating firms review.
- Read the facts and sourcesCurrent status, the court or agency behind it, and the records that usually help.
- Answer a few questionsAbout three minutes. “I'm not sure” is always an option.
- A participating firm follows upOnly with your consent. The firm alone decides whether to take a case.
What changed, and where it came from
- JPMLMonthly pending-case report publishedPending-case counts refreshed on every campaign page with a federal case group, after editor review.View source (opens in a new tab)
- PfizerOxbryta will not return to the U.S. marketStatus stays at Monitoring. There is no consolidated federal case group at this time.View source (opens in a new tab)
- FDAMeningioma added to Depo-Provera warningsFDA approved labeling that adds meningioma to Warnings and Precautions.View source (opens in a new tab)
For law firms
Screened claimants, with consent you can prove.
Campaign-specific screening and TrustedForm certificates on every record. Delivery into your intake system on request.